1-5 of 5
Yueh-Wei Shen
Close
Sort by
Journal Articles

Low Levels of Neurologic Toxicity with Retained Anti-Lymphoma Activity in a Phase I Clinical Trial of T Cells Expressing a Novel Anti-CD19 CAR

Jennifer Brudno, MD, Steven Hartman, Norris Lam, BS, David F. Stroncek, John M. Rossi, MS, Yueh-wei Shen, Allen Xue, PhD, Adrian Bot, MD PhD, Jennifer A Kanakry, MD, Steven Z. Pavletic, MD, Lekha Mikkilineni, MD, Mark Roschewski, MD, Robert M. Dean, MD, Jeremy J. Rose, MS, Rashmika Patel, Brenna Hansen, Steve A. Rosenberg, Ronald E. Gress, MD, James N. Kochenderfer, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 697.
https://doi.org/10.1182/blood-2018-99-113731
Published: 2018
Journal Articles

Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL

Clinical Trials & Observations
John Rossi, Patrick Paczkowski, Yueh-Wei Shen, Kevin Morse, Brianna Flynn, Alaina Kaiser, Colin Ng, Kyle Gallatin, Tom Cain, Rong Fan, Sean Mackay, James R. Heath, Steven A. Rosenberg, James N. Kochenderfer, Jing Zhou, Adrian Bot
Journal: Blood
Blood (2018) 132 (8): 804–814.
https://doi.org/10.1182/blood-2018-01-828343
Published: 2018
Includes: Supplemental data
Journal Articles

Pharmacodynamic Profile and Clinical Response in Patients with B-Cell Malignancies of Anti-CD19 CAR T-Cell Therapy

Arianne Perez, PhD, Lynn Navale, MS, John M. Rossi, MS, Yueh-wei Shen, MS, Yizhou Jiang, PhD, Marika Sherman, MS, Armen Mardiros, PhD, Sean C. Yoder, MS, William Y. Go, MD PhD, Steven A. Rosenberg, MD PhD, Jeff Wiezorek, MD MS, Margo R. Roberts, PhD, David D. Chang, MD PhD, James N. Kochenderfer, MD, Adrian Bot, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2042.
https://doi.org/10.1182/blood.V126.23.2042.2042
Published: 2015
Journal Articles

Cyclophosphamide and Fludarabine Conditioning Chemotherapy Induces a Key Homeostatic Cytokine Profile in Patients Prior to CAR T Cell Therapy

Adrian Bot, MD PhD, John M. Rossi, MS, Yizhou Jiang, PhD, Lynn Navale, MS, Yueh-wei Shen, MS, Marika Sherman, MS, Armen Mardiros, PhD, Sean C. Yoder, MS, William Y. Go, MD PhD, Steven A. Rosenberg, MD PhD, Jeff Wiezorek, MD MS, David D. Chang, MD PhD, James N. Kochenderfer, MD, Margo R. Roberts, PhD
Journal: Blood
Blood (2015) 126 (23): 4426.
https://doi.org/10.1182/blood.V126.23.4426.4426
Published: 2015
Journal Articles

Phase 1 Biomarker Analysis of the ZUMA-1 (KTE-C19-101) Study: A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of Anti-CD19 CAR T Cells (KTE-C19) in Subjects with Refractory Aggressive Non-Hodgkin Lymphoma (NHL)

John M. Rossi, MS, Sattva S. Neelapu, MD, William Y. Go, MD PhD, Yueh-wei Shen, MS, Marika Sherman, MS, Frederick L. Locke, MD, Nancy L Bartlett, MD, Tanya Siddiqi, MD, Lynn Navale, MS, Meg Elias, RN,BSN, Jeff Wiezorek, MD MS, Adrian Bot, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2730.
https://doi.org/10.1182/blood.V126.23.2730.2730
Published: 2015